CAS 2407860-35-7

ErSO

CAS : 2407860-35-7

ErSO

Degré de pureté : ≥98%

Masse moléculaire : 453.33g/mol

Ref: 54-BUP12912

ErSO

CAS : 2407860-35-7

ErSO is a selective activator of anticipatory unfolded protein response (UPR) via ERα receptor. ErSO can be used in studies about anti-cancer.

Formule : C₂₂H₁₃F₆NO₃

Degré de pureté : 98.36%

Couleur et forme : Solid

Masse moléculaire : 453.33

Ref: TM-T39980

Erso

CAS : 2407860-35-7

Erso is a medicinal compound that has been developed to target cancer cells by disrupting the cell cycle and inducing apoptosis. It works by inhibiting the activity of kinases, which are enzymes that play a key role in regulating cell growth and division. Erso has shown promising results in preclinical studies, demonstrating its ability to inhibit tumor growth and induce cancer cell death in both Chinese hamster ovary cells and human cancer cell lines. The protein inhibitor also shows potential for use as a diagnostic tool, as it can be detected in urine samples of patients with certain types of cancer. With its targeted approach to fighting cancer, Erso is poised to become an important tool in the fight against this devastating disease.

Formule : C₂₂H₁₃F₆NO₃

Degré de pureté : Min. 95%

Masse moléculaire : 453.3 g/mol

Ref: 3D-HWD86035